ACC2023 Overview
Upcoming Projects (ACC2023)
-
Don’t see a project related to the keyword you care about? Create your own!
Executed Projects (ACC2023)
-
A second look: Delving into the STELLAR Phase III trial of sotatercept by Merck for the treatment of pulmonary arterial hypertension (PAH) released at ACC2023
Ticker: MRK
Executed On: Mar 17, 2023 at 04:15 PM EDT -
A second look: Delving into the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023
Ticker: ABT
Executed On: Mar 17, 2023 at 12:15 PM EDT -
A third look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 07:00 PM EDT -
A second look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 06:00 PM EDT -
Delving into the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023
Ticker: ABT
Executed On: Mar 14, 2023 at 11:00 AM EDT -
Delving into the STELLAR Phase III trial of sotatercept by Merck for the treatment of pulmonary arterial hypertension (PAH) released at ACC2023
Ticker: MRK
Executed On: Mar 13, 2023 at 05:00 PM EDT -
Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 13, 2023 at 04:00 PM EDT
Upcoming & Overdue Catalysts (ACC2023)
-
Don’t see a catalyst related to the keyword you care about? Create your own!
Strategic Initiatives (ACC2023)
-
Don’t see a strategic initiative related to the keyword you care about? Create your own!
